Physician profile
Robert Asa Scranton
NPI 1861785925
$4,644.84
in general payments reported to CMS, 2019-2025
21 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $52.38 · 2021: $160 · 2022: $68.22 · 2023: $256 · 2024: $2,257 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,817 · Food and Beverage: $1,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,816.64 |
| Food and Beverage | $1,721.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,398.88 | 2023-2025 | Percept PC Brainsense, Stealthstation S8 Platform, Activa PC |
| Medical Device Business Services, INC. | $521.60 | 2019 | |
| Zimmer Biomet Holdings, INC. | $333.04 | 2023-2025 | Neuro Plating System, Omnipore Surgical Implant, Rosa |
| Depuy Synthes Sales INC. | $284.57 | 2019-2025 | Fibergraft Aeridyan Matrix, Teligen |
| Abbott Laboratories | $280.55 | 2023-2025 | Infinity |
| Stryker Corporation | $224.94 | 2019-2024 | Duramatrix |
| Providence Medical Technology, INC. | $117.32 | 2025 | |
| Integra Lifesciences Corporation | $80.03 | 2020-2024 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Ge Healthcare | $65.93 | 2019 | |
| Medtronic USA, INC. | $64.14 | 2019 | |
| Aesculap, INC. | $59.87 | 2021 | |
| Globus Medical, INC. | $42.34 | 2025 | Harvest |
| Novartis Pharmaceuticals Corporation | $31.83 | 2021 | |
| Spinal Elements, INC. | $28.03 | 2024 | |
| Insightec,INC | $25.39 | 2025 | Exablate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.32 | 2022 | |
| Incyte Corporation | $14.90 | 2019 | |
| Seagen INC. | $14.62 | 2019 | |
| Verastem, INC. | $13.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.87 | 2021 | |
| Janssen Biotech, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Scranton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.